Alyeska Wrote Both Checks and the Market Missed It
I am long MRLN at an average of $6.03. This is a 41.7% position in the Shawarma Capital portfolio. As of today, May 1, 2026, MRLN trades at $10.00, up 11.1% on the session and up 65.8% from entry. The April 29 PIPE dropped the stock 22% in a single session. Conviction is unchanged. This post is research synthesis, not investment advice.
On April 29, 2026, Merlin filed an 8-K. The body of that filing described the buyer of an $80 million private placement only as “the purchaser named therein.” The Exhibit 99.1 press release characterized the buyer as “an existing fundamental institutional shareholder.” The buyer was named in Exhibit 10.1 (the Securities Purchase Agreement): Alyeska Master Fund, L.P., the fund vehicle managed by Alyeska Investment Group, L.P.
Alyeska is not a passive long-only fund that saw a dip and wrote a check. Alyeska, founded in 2008 by Anand Parekh (ex-Citadel global head of equities), manages approximately $15 billion in assets from Chicago and runs a discretionary long/short equity book. Alyeska already held 9,803,922 preferred shares plus matching warrants from the original $120 million preferred PIPE, representing $100 million of that raise. That preferred position carries full-ratchet antidilution protection under Section 7(c) of the Series A Certificate of Designation.
Here is the structure: Alyeska anchors the new $80 million PIPE at $10 per share. That issuance, priced below the existing $12.00 conversion price on the preferred, triggers the Section 7(c) full-ratchet. The conversion price on Alyeska's existing $100 million preferred position resets downward. Alyeska writes the new check and simultaneously sweetens the economics on the old check. One entity. Both sides of the trade.
The market read this as dilution. The market is not wrong about the dilution. But it missed the structure entirely.
Let's go.
